Papers - TERAKURA Seitaro
-
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells. Reviewed
Terakura S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR.
Blood Vol. 119 ( 1 ) page： 72-82 2011.10
-
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies. Reviewed
Terakura S, Atsuta Y, Sawa M, Ohashi H, Kato T, Nishiwaki S, Imahashi N, Yasuda T, Murata M, Miyamura K, Suzuki R, Naoe T, Ito T, Morishita Y; Nagoya Blood and Marrow Transplantation Group.
Annals of Oncology Vol. 22 ( 8 ) page： 1865-1871 2011.2
-
CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease. Reviewed
Sugimoto K, Murata M, Terakura S, Naoe T.
The Journal of Immunology Vol. 183 ( 9 ) page： 5991-5998 2009.10
-
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Reviewed
Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Tsukamoto S, Shimba M, Ozawa Y, Miyamura K.
Blood Vol. 114 ( 14 ) page： 3113-3116 2009.7
-
A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403. Reviewed
Terakura S, Murata M, Warren EH, Sette A, Sidney J, Naoe T, Riddell SR.
Transplantation. Vol. 83 ( 9 ) page： 1242-1248 2007.5
-
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Reviewed
Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y, Kodera Y, Yazaki M, Naoe T, Kato K.
Biol Blood Marrow Transplant. Vol. 13 ( 7 ) page： 822-830 2007.4
-
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Reviewed
Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y.
Bone Marrow Transplant. Vol. 39 ( 1 ) page： 31-39 2006.11
-
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients. Reviewed
Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Morishima Y, Kodera Y, Naoe T.
Bone Marrow Transplant. Vol. 37 ( 4 ) page： 381-386 2006.1
-
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation. Reviewed
Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Riddell SR, Morishima Y, Kodera Y, Naoe T.
Br J Haematol Vol. 129 ( 2 ) page： 221-228 2005.4
-
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Reviewed
Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.
Bone Marrow Transplant. Vol. 33 ( 11 ) page： 1143-1150 2004.4